Form 4 Filing for CG Oncology, Inc. - Director Stock Option Grant

This filing details a Form 4 submission by CG Oncology, Inc. concerning a stock option grant to director Liu Brian Guan-Chyun. The grant, dated June 4, 2026, includes 9,354 stock options with a right to buy common stock. The options vest monthly over 12 months starting from the grant date, contingent upon continuous service. The exercise price is $56.09, and the expiration date is June 3, 2036. The filing was signed by Joshua F. Patterson as Attorney-in-Fact for Brian Guan-Chyun Liu on June 5, 2026.